Friday, 18 November 2016

Spectrum Pharma says U.S. FDA rejects its bladder cancer drug

(Reuters) - Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration rejected the drugmaker's bladder cancer treatment.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)